SCHEMBL28446403

SCHEMBL28446403

CC(C)C(NC(=O)OC(C)(C)C)c1nc2cc(Br)sc2c(=O)[nH]1

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ABCB1 P08183 5/20 0.37
▸ AAK1 Q2M2I8 5/20 0.37
▸ KMT2A Q03164 2/20 0.34
▸ TSHR P16473 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ LMNA P02545 3/20 0.33
▸ PPARG P37231 1/20 0.33
▸ NCOA2 Q15596 1/20 0.33
▸ NCOA1 Q15788 1/20 0.33
▸ NCOA3 Q9Y6Q9 1/20 0.33
▸ CA1 P00915 1/20 0.32
▸ CA2 P00918 1/20 0.32
▸ CA7 P43166 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21712595 0.85 KMT2A (0.39) KMT2AMEN1
SCHEMBL28459863 0.84 AAK1 (0.42) ABCB1AAK1ALDH1A1
SCHEMBL21729584 0.82 AAK1 (0.37) ABCB1AAK1KMT2ATSHRMEN1
SCHEMBL21729515 0.81 AAK1 (0.37) ABCB1AAK1KMT2ATSHRMEN1
SCHEMBL21729500 0.81 AAK1 (0.42) ABCB1AAK1KMT2AMEN1LMNA
SCHEMBL21729559 0.81 AAK1 (0.35) ABCB1AAK1KMT2AMEN1
SCHEMBL21729586 0.81 AAK1 (0.39) ABCB1AAK1KMT2ATSHRMEN1
SCHEMBL21729495 0.81 CDC7 (0.43) ABCB1AAK1KMT2AMEN1LMNA
SCHEMBL21729493 0.81 AAK1 (0.42) ABCB1AAK1KMT2AMEN1LMNA
SCHEMBL28453787 0.81 CDC7 (0.43) ABCB1AAK1KMT2AMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112409373-A Substituted [5,6] cyclo-4 (3H) -pyrimidinones as anticancer agents 南京正济医药研究有限公司 2021-02-26 — — CN disclosed
CN-110381950-B Substituted [5,6] cyclo-4 (3H) -pyrimidinones as anticancer agents 南京正济医药研究有限公司 2020-09-04 — — CN disclosed
Send feedback